This article is a continuation of the chat shared earlier with HAI on Coffee with HAI. In that chat, there was a discussion on the likely side effects from COVID vaccine such as thyroid autoimmune diseases and neuropathic issues. Please note that this is not to question the utility of vaccines, but more so to address issues seen with a new type of vaccine that got administered for COVID.
As part of this presentation, please see excerpts from that chat prior to jumping into medical references on this topic.
Dr SSK:
Pertaining to this, there have been reports of COVID vaccines causing
thyroid issues, myocarditis, neuropathy, and other health challenges. There were
reports that this kind of study was restricted even in governmental organizations
during COVID times. Now that more studies are coming out, what is your take on it?
HAI:
The COVID-19 vaccines have been a crucial tool in combating the pandemic, but like all medical interventions, they have been associated with some side effects. Here are some key points regarding the health challenges and the studies surrounding them:
Reported Side Effects: There have been reports of various side effects, including thyroid issues, myocarditis (inflammation of the heart muscle), and neuropathy (nerve damage). These side effects are generally rare but have been documented in some cases.
Myocarditis: This condition has been observed more frequently in younger males following mRNA COVID-19 vaccination. Most cases are mild and resolve with appropriate treatment, but it has been a point of concern and ongoing study.
Thyroid Issues and Neuropathy: There have been isolated reports of thyroid dysfunction and neuropathy following vaccination. These are being investigated to understand any potential causal links.
Research and Transparency: During the height of the pandemic, the urgency of vaccine rollout sometimes led to limited initial data on long-term effects. However, ongoing studies and post-marketing surveillance have been crucial in identifying and understanding these side effects. Transparency and open communication about these findings are essential for public trust.
Regulatory Oversight: Regulatory bodies like the FDA and EMA continue to monitor vaccine safety and efficacy. They have systems in place to investigate and respond to reports of adverse effects.
Balancing Risks and Benefits: It's important to balance the rare risks of side effects with the benefits of vaccination, which include preventing severe illness, hospitalization, and death due to COVID-19.
The evolving nature of scientific research means that new findings will continue to emerge. It's crucial to rely on credible sources and ongoing studies to stay informed. If you have specific concerns or need more detailed information, consulting healthcare professionals or trusted medical sources is always a good approach.
From
the above excerpts, we can see that even HAI is not fully aware of
Thyroid and Neuropathy issues, though there have been more and more
studies coming out with even databases available. For that reason, we
are sharing a set of references on the side effects of COVID vaccines.
Please note again that this is not to question the usefulness of this
vaccine, but more to be aware of the likely side effects coming out of
this vaccine. For that matter, there are programs such as CICP and VICP
supposedly in place for that purpose.
To be cont'd with more references. This article will also encompass our Eyeperspective from a set of interesting experiences.
REFERENCES:
THYROID AUTO IMMUNE DISEASES FROM VACCINE, extracted just from the above-mentioned article
- 1.WHO Coronavirus (COVID-19) Dashboard. February, 2022
- 2.Giovanella L, Ruggeri RM, Petranović Ovčariček P, Campenni A, Treglia G, Deandreis D. SARS-CoV-2-related thyroid disorders: a synopsis for nuclear medicine thyroidologists. Eur J Nucl Med Mol Imaging. 2021;48:1719–1723. doi: 10.1007/s00259-021-05316-0. [DOI] [PubMed] [Google Scholar]
- 3.Piticchio T, Le Moli R, Tumino D, Frasca F. Relationship between betacoronaviruses and the endocrine system: a new key to understand the COVID-19 pandemic—a comprehensive review. J Endocrinol Invest. 2021;44:1553–1570. doi: 10.1007/s40618-020-01486-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Giovanella L, Ruggeri RM, Petranović Ovčariček P, Campenni A, Treglia G, Deandreis D. Prevalence of thyroid dysfunction in patients with COVID-19: a systematic review. Clin Transl Imaging. 2021;9:233–240. doi: 10.1007/s40336-021-00419-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Rotondi M, Coperchini F, Ricci G, Denegri M, Croce L, Ngnitejeu ST, Villani L, Magri F, Latrofa F, Chiovato L. Detection of SARS-COV-2 receptor ACE-2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis. J Endocrinol Invest. 2021;44:1085–1090. doi: 10.1007/s40618-020-01436-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Vojdani A, Kharrazian D. Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases. Clin Immunol. 2020;217:108480. doi: 10.1016/j.clim.2020.108480. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Kanduc D, Shoenfeld Y. On the molecular determinants of the SARS-CoV-2 279 attack. Clin Immunol. 2020;215:108426. doi: 10.1016/j.clim.2020.108426. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Ruggeri RM, Campennì A, Deandreis D, Siracusa M, Tozzoli R, Petranović Ovčariček P, Giovanella L. SARS-COV-2-related immune-inflammatory thyroid disorders: facts and perspectives. Expert Rev Clin Immunol. 2021;17:737–759. doi: 10.1080/1744666X.2021.1932467. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Chung YH, Beiss V, Fiering SN, Steinmetz NF. COVID-19 vaccine frontrunners and their nanotechnology design. ACS Nano. 2020;14:12522–21253. doi: 10.1021/acsnano.0c07197. [DOI] [PubMed] [Google Scholar]
- 10.Chen Y, Xu Z, Wang P, Li XM, Shuai ZW, Ye DQ, Pan HF. New-onset autoimmune phenomena post-COVID-19 vaccination. Immunology. 2022;165:386–440. doi: 10.1111/imm.13443. [DOI] [PubMed] [Google Scholar]
- 11.Ippolito S, Gallo D, Rossini A, Patera B, Lanzo N, Fazzino GFM, Piantanida E, Tanda ML. SARS-CoV-2 vaccine-associated subacute thyroiditis: insights from a systematic review. J Endocrinol Invest. 2022;29:1–12. doi: 10.1007/s40618-022-01747-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Yorulmaz G, Sahin Tekin M. SARS-CoV-2 vaccine-associated subacute thyroiditis. J Endocrinol Invest. 2022;45:1341–1347. doi: 10.1007/s40618-022-01767-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Jafarzadeh A, Nemati M, Jafarzadeh S, Nozari P, Mortazavi SMJ. Thyroid dysfunction following vaccination with COVID-19 vaccines: a basic review of the preliminary evidence. J Endocrinol Invest. 2022;26:1–29. doi: 10.1007/s40618-022-01786-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Pujol A, Gómez LA, Gallegos C, Nicolau J, Sanchís P, González-Freire M, López-González ÁA, Dotre K, Masmiquel L. Thyroid as a target of adjuvant autoimmunity/inflammatory syndrome due to mRNA-based SARS-CoV2 vaccination: from Graves' disease to silent thyroiditis. J Endocrinol Invest. 2022;45:875–882. doi: 10.1007/s40618-021-01707-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Vera-Lastra O, Ordinola Navarro A, Cruz Domiguez MP, Medina G, Sanchez Valadez TI, Jara LJ. Two cases of Graves’ disease following SARS-CoV-2 vaccination: an autoimmune/infammatory syndrome induced by adjuvants. Thyroid. 2021;31:1436–1439. doi: 10.1089/thy.2021.0142. [DOI] [PubMed] [Google Scholar]
- 16.Zettining G, Krebs M. Two further cases of Graves' disease following SARS-CoV-2 vaccination. J Endocrinol Invest. 2021;45:227–228. doi: 10.1007/s40618-021-01650-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Taieb A, Sawsen N, Asma BA, Ghada S, Hamza E, Yosra H, Amel M, Molka C, Maha K, Koussay A. A rare case of Grave's disease after SARS-CoV-2 vaccine: is it an adjuvant effect? Eur Rev Med Pharmacol Sci. 2022;26:2627–2630. doi: 10.26355/eurrev_202204_28500. [DOI] [PubMed] [Google Scholar]
- 18.Bostan H, Ucan B, Kizilgul M, Calapkulu M, Hepsen S, Gul U, Ozturk Unsal I, Cakal E. Relapsed and newly diagnosed Graves' disease due to immunization against COVID-19: A case series and review of the literature. J Autoimmun. 2022;128:102809. doi: 10.1016/j.jaut.2022.102809. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Chee YJ, Liew H, Hoi WH, Lee Y, Lim B, Chin HX, Lai RTR, Koh Y, Tham M, Seow CJ, Quek ZH, Chen AW, Quek TPL, Tan AWK, Dalan R. SARS-CoV-2 mRNA vaccination and Graves' disease: a report of 12 cases and review of the literature. J Clin Endocrinol Metab. 2022;107:e2324–e2330. doi: 10.1210/clinem/dgac119. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Rubinstein TJ. Thyroid eye disease following COVID-19 vaccine in a patient with a history Graves’ disease: a case report. Ophthalmic Plast Reconstr Surg. 2021;37:e221–e223. doi: 10.1097/IOP.0000000000002059. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Park KS, Fung SE, Ting M, Ozzello DJ, Yoon JS, Liu CY, Korn BS, Kikkawa DO. Thyroid eye disease reactivation associated with COVID-19 vaccination. Taiwan J Ophthalmol. 2022;12:93–96. doi: 10.4103/tjo.tjo. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Patrizio A, Ferrari SM, Antonelli A, Fallahi P. Worsening of Graves' ophthalmopathy after SARS-CoV-2 mRNA vaccination. Autoimmun Rev. 2022;9:103096. doi: 10.1016/j.autrev.2022.103096. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Siolos A, Gartzonika K, Tigas S. Thyroiditis following vaccination against COVID-19: Report of two cases and review of the literature. Metabol Open. 2021;12:100136. doi: 10.1016/j.metop.2021.100136. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Giusti M, Maio A. Acute thyroid swelling with severe hypothyroid myxoedema after COVID-19 vaccination. Clin Case Reports. 2021;9:e05217. doi: 10.1002/ccr3.5217. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Ruggeri RM, Giuffrida G, Campennì A. Autoimmune endocrine diseases. Minerva Endocrinol. 2018;43:305–322. doi: 10.23736/S0391-1977.17.02757-2. [DOI] [PubMed] [Google Scholar]
- 26.Burch EB. Drug effects on the thyroid. N Engl J Med. 2019;381:749–756. doi: 10.1056/NEJMra1901214. [DOI] [PubMed] [Google Scholar]
- 27.Olivieri B, Betterle C, Zanoni G. Vaccinations and autoimmune diseases. Vaccines (Basel) 2021;9:815. doi: 10.3390/vaccines9080815. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Vojdani A, Vojdani E, Kharrazian D. Reaction of human monoclonal antibodies to SARS-CoV-2 proteins with tissue antigens: implications for autoimmune diseases. Front Immunol. 2020;11:617089. doi: 10.3389/fimmu.2020.617089. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Shoenfeld Y, Agmon-Levin N. “ASIA”—autoimmune/infammatory syndrome induced by adjuvants. J Autoimmun. 2021;36:4–8. doi: 10.1016/j.jaut.2010.07.003. [DOI] [PubMed] [Google Scholar]
- 30.Watad A, David P, Brown S, Shoenfeld Y. Autoimmune/inflammatory syndrome induced by adjuvants and thyroid autoimmunity. Front Endocrinol (Lausanne) 2017;7:150. doi: 10.3389/fendo.2016.00150. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Bragazzi N, Hejly A, Watad A, Adawi M, Amital H, Shoenfeld Y. ASIA syndrome and endocrine autoimmune disorders. Best Pract Res Clin Endocrinol Metab. 2020;34:101412. doi: 10.1016/j.beem.2020.101412. [DOI] [PubMed] [Google Scholar]
- 32.Mathieu E, Ritchie H, Ortiz-Ospina E, Roser M, Hasell J, Appel C, Giattino C, Rodés-Guirao LA. A global database of COVID-19 vaccinations. Nat Hum Behav. 2021;5:947–953. doi: 10.1038/s41562-021-01122-8. [DOI] [PubMed] [Google Scholar]
NEUROPATHY CONCERNS FROM COVID VACCINES
- 1. Waheed W, Carey ME, Tandan SR, Tandan R. Post COVID-19 vaccine small fiber neuropathy. Muscle and Nerve. 2021;64(1):E1–2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Khokhar F, Khan A, Hussain Z, Yu J. Small fiber neuropathy associated with the Moderna SARS-CoV-2 vaccine. Cureus. 2022;14(6):e25969–2. 10.7759/cureus.25969. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Oaklander AL, Mills AJ, Kelley M, Toran LS, Smith B, Dalakas MC, et al. Peripheral neuropathy evaluations of patients with prolonged long COVID. Neurol Neuroimmunol Neuroinflamm. 2022 May 1;9(3):e1146. 10.1212/NXI.0000000000001146. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Safavi F, Gustafson L, Walitt B, Lehky T, Dehbashi S, Wiebold A, et al. Neuropathic symptoms with SARS-CoV-2 vaccination. medRxiv. 2022;202205.16.22274439. 10.1101/2022.05.16.22274439. [DOI] [Google Scholar]
- 5. Lahoz Fernandez PE, Miranda Pereira J, Fonseca Risso I, Baleeiro Rodrigues Silva P, Freitas Barboza IC, Vieira Silveira CG, et al. Guillain-Barre syndrome following COVID-19 vaccines: a scoping review. Acta Neurol Scand. 2022 Apr 1;145(4):393–8. 10.1111/ane.13575. [DOI] [PubMed] [Google Scholar]
- 6. Keh RYS, Scanlon S, Datta-Nemdharry P, Donegan K, Cavanagh S, Foster M, et al. COVID-19 vaccination and Guillain-Barré syndrome: analyses using the National Immunoglobulin Database. Brain. 2022 Feb 18;awac067. 10.1093/brain/awac067. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Novak P, Giannetti MP, Weller E, Hamilton MJ, Mukerji SS, Alabsi HS, et al. Network autonomic analysis of post-acute sequelae of COVID-19 and postural tachycardia syndrome. Neurol Sci. 2022;43(12):6627–38. 10.1007/s10072-022-06423-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Abrams RMC, Simpson DM, Navis A, Jette N, Zhou L, Shin SC. Small fiber neuropathy associated with SARS-CoV-2 infection. Muscle Nerve. 2022;65(4):440–3. 10.1002/mus.27458. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Trevino JA, Novak P. TS-HDS and FGFR3 antibodies in small fiber neuropathy and Dysautonomia. Muscle Nerve. 2021 Jul 1;64(1):70–6. 10.1002/mus.27245. [DOI] [PubMed] [Google Scholar]
- 10. Gemignani F, Bellanova F, Saccani E, Pavesi G. Non-length-dependent small fiber neuropathy: not a matter of stockings and gloves. Muscle Nerve. 2022;65(1):10–28. [DOI] [PubMed] [Google Scholar]
- 11. Gibbons C. IVIg for small fiber neuropathy with autoantibodies TS-HDS and FGFR3. Clinicaltrials.gov. 2021 Apr 19. [Google Scholar]
- 12. Kumar SS, Yong MH, Koh YH. Small fiber neuropathy in a patient with coronavirudisease 2019 (COVID-19). Neurol Asia. 2022;27(1):195–7. [Google Scholar]
- 13. Tsakadze N, Catania J, Hoffmann M, Benes-lima L, Estevez AG, Franco MC. Case report: length-dependent small fiber polyneuropathy caused by Coxsackie and Influenza virus Co- infection. 2019;103–5. [Google Scholar]
- 14. Tholance Y, Moritz CP, Rosier C, Ferraud K, Lassablière F, Reynaud-Federspiel E, et al. Clinical characterisation of sensory neuropathy with anti-FGFR3 autoantibodies. J Neurol Neurosurg Psychiatry. 2020 Jan 1;91(1):49–57. 10.1136/jnnp-2019-321849. [DOI] [PubMed] [Google Scholar]
ARCHIVES